These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34747523)

  • 1. Conditional information and inference in response-adaptive allocation designs.
    Lane A
    Stat Med; 2022 Jan; 41(2):390-406. PubMed ID: 34747523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.
    Zhao J; Yu M; Feng XP
    BMC Med Res Methodol; 2015 Jun; 15():48. PubMed ID: 26048655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional estimation in two-stage adaptive designs.
    Broberg P; Miller F
    Biometrics; 2017 Sep; 73(3):895-904. PubMed ID: 28099993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of conditional and unconditional randomization tests for highly stratified designs.
    Flyer PA
    Biometrics; 1998 Dec; 54(4):1551-9. PubMed ID: 9883551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-randomization tests in clinical trials.
    Proschan MA; Dodd LE
    Stat Med; 2019 May; 38(12):2292-2302. PubMed ID: 30672002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and analysis of drop-the-losers studies using binary endpoints in the rare disease setting.
    Jazić I; Liu X; Laird G
    J Biopharm Stat; 2021 Jul; 31(4):507-522. PubMed ID: 34053399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible design of two-stage adaptive procedures for phase III clinical trials.
    Koyama T
    Contemp Clin Trials; 2007 Jul; 28(4):500-13. PubMed ID: 17307399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal design for inference on the threshold of a biomarker.
    Baldi Antognini A; Frieri R; Rosenberger WF; Zagoraiou M
    Stat Methods Med Res; 2024 Feb; 33(2):321-343. PubMed ID: 38297878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some challenges with statistical inference in adaptive designs.
    Hung HM; Wang SJ; Yang P
    J Biopharm Stat; 2014; 24(5):1059-72. PubMed ID: 24915027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Start-up designs for response-adaptive randomization procedures with sequential estimation.
    Haines LM; Sadiq H
    Stat Med; 2015 Sep; 34(21):2958-70. PubMed ID: 25944171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size and the width of the confidence interval for mean difference.
    Liu XS
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):201-15. PubMed ID: 18208638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probability of success and group sequential designs.
    Grieve AP
    Pharm Stat; 2024; 23(2):185-203. PubMed ID: 37916276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exact unconditional inference for risk ratio in a correlated 2 x 2 table with structural zero.
    Tang NS; Tang ML
    Biometrics; 2002 Dec; 58(4):972-80. PubMed ID: 12495152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population Group.
    Ryeznik Y; Sverdlov O; Hooker AC
    AAPS J; 2018 Jul; 20(5):85. PubMed ID: 30027336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A variational approach to optimal two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2019 Sep; 38(21):4159-4171. PubMed ID: 31264243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.